Authors: Schuler, M Herrmann, R De Greve, JLP Stewart, AK Gatzemeier, U Stewart, DJ Laufman, L Gralla, R Kuball, J Buhl, R Heussel, CP Kommoss, F Perruchoud, AP Shepherd, FA Fritz, MA Horowitz, JA Huber, C Rochlitz, C

Citation: M. Schuler et al., Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: Results of a multicenter phase II study, J CL ONCOL, 19(6), 2001, pp. 1750-1758

Authors: Shepherd, FA Dancey, J Ramlau, R Mattson, K Gralla, R O'Rourke, M Levitan, N Gressot, L Vincent, M Burkes, R Coughlin, S Kim, Y Berille, J

Citation: Fa. Shepherd et al., Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy, J CL ONCOL, 18(10), 2000, pp. 2095-2103

Authors: Gralla, R Harper, P Johnson, S Delgado, FM

Citation: R. Gralla et al., Vinorelbine (Navelbine (R)) in the treatment of non-small-cell lung cancer: Studies with single-agent therapy and in combination with cisplatin, ANN ONCOL, 10, 1999, pp. 41-45

Authors: Gralla, R Harper, P Johnson, S Delgado, FM

Citation: R. Gralla et al., Vinorelbine (Navelbine (R)) in the treatment of non-small-cell lung cancer: Recent developments in combination chemotherapy and radiotherapy, ANN ONCOL, 10, 1999, pp. 47-51

Authors: Gralla, R Harper, P Johnson, S Delgado, FM

Citation: R. Gralla et al., Vinorelbine (Navelbine (R)) in the treatment of non-small-cell lung cancer: Studies with single-agent therapy and in combination with cisplatin. (vol10, pg S41, 1999), ANN ONCOL, 10(12), 1999, pp. 1533-1533

Authors: von Pawel, J Schiller, JH Shepherd, FA Fields, SZ Kleisbauer, JP Chrysson, NG Stewart, DJ Clark, PI Palmer, MC Depierre, A Carmichael, J Krebs, JB Ross, G Lane, SR Gralla, R

Citation: J. Von Pawel et al., Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer, J CL ONCOL, 17(2), 1999, pp. 658-667